Evoke Pharma Inc Annual Return On Equity in % from 2014 to 2023

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Evoke Pharma Inc quarterly/annual Return On Equity history and growth rate from 2014 to 2023.
  • Evoke Pharma Inc Return On Equity for the quarter ending September 30, 2024 was -309 %, a 40.4% increase year-over-year.
  • Evoke Pharma Inc annual Return On Equity for 2023 was 3.95K %.
  • Evoke Pharma Inc annual Return On Equity for 2022 was -176 %, a 13.6% decline from 2021.
  • Evoke Pharma Inc annual Return On Equity for 2021 was -155 %, a 108% decline from 2020.
Return On Equity, Annual (%)
Return On Equity, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date
2023 3.95K +4.13K Jan 1, 2023 Dec 31, 2023
2022 -176 -21 -13.6% Jan 1, 2022 Dec 31, 2022
2021 -155 -2.19K -108% Jan 1, 2021 Dec 31, 2021
2020 2.03K +2.18K Jan 1, 2020 Dec 31, 2020
2019 -150 +7.56 +4.79% Jan 1, 2019 Dec 31, 2019
2018 -158 +101 +39% Jan 1, 2018 Dec 31, 2018
2017 -258 +298 +53.6% Jan 1, 2017 Dec 31, 2017
2016 -557 -308 -124% Jan 1, 2016 Dec 31, 2016
2015 -248 -151 -155% Jan 1, 2015 Dec 31, 2015
2014 -97.2 Jan 1, 2014 Dec 31, 2014
* An asterisk sign (*) next to the value indicates that the value is likely invalid.